(Q43792074)

26 November 2017

title

Long-term follow-up of hepatitis A vaccination in children (English)

1 reference

26 November 2017

1 reference

Chan CY

1

1 reference

26 November 2017

Lee SD

2

1 reference

26 November 2017

Yu MI

3

1 reference

26 November 2017

Wang YJ

4

1 reference

26 November 2017

Chang FY

5

1 reference

26 November 2017

Lo KJ

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

26 November 2017

1 reference

26 November 2017

volume

17

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

369-372

1 reference

Incidence of Hepatitis A Virus Infection in Children in Taipei, Taiwan

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Changing seroepidemiology of hepatitis A virus infection in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Immunogenicity of inactivated hepatitis A vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Comparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Hepatitis A vaccine responses in HIV-positive persons with haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

A study to assess the immunogenicity, reactogenicity and safety of hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900200-X

7 January 2021

10.1016/S0264-410X(98)00200-X

Identifiers

DOI

1 reference

26 November 2017

1 reference